Dublin, March 07, 2017 -- Research and Markets has announced the addition of the "The Market for Mass Spectrometry in Clinical Testing Applications" report to their offering.
The Market for Mass Spectrometry in Clinical Testing Applications covers the global opportunity for mass spectrometry instruments and consumables, including mass spectrometry revenues for 2016 and 2021, regional markets for 2016 and 2021 (North America, Europe, Asia, Rest of World, Total Market), and mass spectrometry revenues by manufacturer for 2016 (%). The report provides revenue analysis and company activity in the market, such as mergers and agreements.
Agilent, SCIEX, and Thermo Fisher Scientific are among the manufacturers discussed in the report's competitor analysis.
Key Topics Covered:
Chapter 1: Executive Summary
- Market Overview
- Future Prospects in the Mass Spectrometry Market
Chapter 2: Introduction
- Brief History of Mass Spectrometry
- Point-of-View
Chapter 3: Mass Spectrometry Overview
- Types of Mass Spectrometry - Overview
- Companies Marketing Mass Spectrometry Platforms and Related Products
- Mass Spectrometry Platforms in the Clinical Laboratory
Chapter 4: Mass Spectrometry in Research and the Clinical Laboratory
- Research Applications of Mass Spectrometry
- Mass Spectrometry in the Clinical Laboratory
- Early Applications of Mass Spectrometry in the Clinical Laboratory
- Oncology
- Infectious Disease
- Other Clinical Applications of Mass Spectrometry
- Other Applications of Mass Spectrometry
Chapter 5: Deals - Mass Spectrometry Companies
- Investments and Financing Agreements
- Mergers and Acquisitions
- Other Corporate Agreements and Collaborations
- Collaborations/Agreements Between Two Mass Spectrometry Companies
- Collaborations/Agreements with Diagnostic Companies and/or Clinical Laboratories
- Collaborations/Agreements with Pharmaceutical and Biopharmaceutical Companies
- Other Company Collaborations/Agreements
- Collaborations and Other Agreements with Universities, Non-Profit Research Institutes and Government
Chapter 6: Mass Spectrometry in the Clinical Laboratory - Market Drivers and Challenges
- Mass Spectrometry Technology and Platforms
- Need for Integration of Pre-analytical, Analytical, and Post-analytical Components of Mass Spectrometry Based Assays; Advances in Mass Spectrometry Platforms
- Mass Spectrometry vs. Immunoassays - Advantages and Disadvantages
- Mass Spectrometry Clinical Market Drivers
- Increasing Number of Clinical Applications for Mass Spectrometry
- Oncology Market Drivers
- Newborn Screening and Genetic Analysis Market Drivers
- Infectious Disease Market Drivers
- Market Drivers for Other Segments of the Clinical Mass Spectrometry Market
- Competition
- Potential Impact of Mass Spectrometry on Other Markets
- Most Mass Spectrometry Clinical Assays Today are Laboratory Developed Tests (LDTs)
- Regulation of Mass Spectrometry-Based In Vitro Diagnostic (IVD) Tests
- Future Prospects
Chapter 7: Mass Spectrometry Market Analysis
- Mass Spectrometry Market Overview
- Research versus Clinical Mass Spectrometry Market
- Mass Spectrometry Market - Geographical Distribution
- Mass Spectrometry Market - Market Shares by Company
- Mass Spectrometry Market (Products Sold to Clinical Laboratories) - By Intended Clinical Category, 2016
- Mass Spectrometry Market - By Type of Mass Spectrometer
Chapter 8: Company Profiles - Mass Spectrometry Companies
- Abbott Laboratories
- Advion, Inc.
- Agena Bioscience, Inc.
- Applying MassARRAY System to Clinical Diagnostics
- Agilent Technologies Inc.
- Andromas SAS
- Applied Proteomics, Inc.
- Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
- Revenue History
- Biocrates Life Sciences AG
- Biodesix, Inc.
- Biodesix Lung Reflex
- Research Activities
- Investors/Financings
- Other Agreements
- Biognosys AG
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Caprion Biosciences, Inc.
- caprotec bioanalytics GmbH
- Danaher Corporation
- Fluidigm Corporation
- ImaBiotech
- Integrated Diagnostics, Inc.
- Selected Deals
- Indi Molecular
- KineMed, Inc.
- Microsaic Systems plc
- PerkinElmer, Inc.
- Proteome Sciences plc
- Sera Prognostics, Inc.
- Shimadzu Corporation
- Thermo Fisher Scientific, Inc.
- Waters Corporation
For more information about this report visit http://www.researchandmarkets.com/research/7ksrfn/the_market_for
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Healthcare Services


Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 



